Cargando…

Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis

Detalles Bibliográficos
Autores principales: Hughes, Robert M., Frey, Sarah, Teles, Mayan, Connolly, Caoilfhionn M., Segev, Dorry L., Werbel, William A., Chen, Po-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the AGA Institute. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073076/
https://www.ncbi.nlm.nih.gov/pubmed/37360678
http://dx.doi.org/10.1016/j.gastha.2023.03.025
_version_ 1785019512926502912
author Hughes, Robert M.
Frey, Sarah
Teles, Mayan
Connolly, Caoilfhionn M.
Segev, Dorry L.
Werbel, William A.
Chen, Po-Hung
author_facet Hughes, Robert M.
Frey, Sarah
Teles, Mayan
Connolly, Caoilfhionn M.
Segev, Dorry L.
Werbel, William A.
Chen, Po-Hung
author_sort Hughes, Robert M.
collection PubMed
description
format Online
Article
Text
id pubmed-10073076
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc. on behalf of the AGA Institute.
record_format MEDLINE/PubMed
spelling pubmed-100730762023-04-05 Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis Hughes, Robert M. Frey, Sarah Teles, Mayan Connolly, Caoilfhionn M. Segev, Dorry L. Werbel, William A. Chen, Po-Hung Gastro Hep Adv Research Letter Published by Elsevier Inc. on behalf of the AGA Institute. 2023-04-05 /pmc/articles/PMC10073076/ /pubmed/37360678 http://dx.doi.org/10.1016/j.gastha.2023.03.025 Text en © 2023 Published by Elsevier Inc. on behalf of the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Hughes, Robert M.
Frey, Sarah
Teles, Mayan
Connolly, Caoilfhionn M.
Segev, Dorry L.
Werbel, William A.
Chen, Po-Hung
Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
title Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
title_full Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
title_fullStr Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
title_full_unstemmed Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
title_short Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
title_sort durability of antibody response six months after two-dose sars-cov-2 mrna vaccination in patients with cirrhosis
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073076/
https://www.ncbi.nlm.nih.gov/pubmed/37360678
http://dx.doi.org/10.1016/j.gastha.2023.03.025
work_keys_str_mv AT hughesrobertm durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis
AT freysarah durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis
AT telesmayan durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis
AT connollycaoilfhionnm durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis
AT segevdorryl durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis
AT werbelwilliama durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis
AT chenpohung durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis